We are looking for experts in "proteomics" to provide commentary and insights towards a startup that is pioneering the next-generation of proteomics, wherein many proteins can be analyzed simultaneously in samples as minimal as a single cell or drop of blood.
We are an angel investing platform dedicated to connecting deep-tech startups with angel investors. By deep-tech we mean startups founded on scientific breakthroughs and technological innovations that create lasting impact on mankind.
As a participating expert* in this process, your involvement is limited to answering anywhere between 8-12 investor-submitted questions. This takes about 1 hour (+/-) . Once you are vetted, we send those questions via a web form for your responses. If your contribution is published, it will be view-able by potential investors in this startup, giving you an opportunity to make connections, socialize virtually, and gain bragging rights in a vibrant entrepreneurial and angel investing community.
*at this point, we cannot guarantee any monetary reimbursement. You do get insights to new upcoming technologies in your field and a tremendous networking opportunity!+23 Other Responses
Pharmaceutical Pricing And Reimbursment
I hope this email finds you well. I am a reporter.
I am looking to speak with p&r experts to discuss portola’s andexanet alfa for the reversal of factor xa inhibitor activity.
I was wondering if you had time this week or in the near future to discuss this with me? You can appear on background if you wish.
Happy to send you press releases/analyst reports if you are interested.
Many thanks and please let me know,
alexandra+14 Other Responses